Showing results (171-180 of 2,377) with videos related to

Sort By:
Pageof 238
Journal of Hazardous Materials|January 16, 2015
Anaerobic biodegradation of nonylphenol in river sediment under nitrate- or sulfate-reducing conditions and associated bacterial communityZhao Wang, Yuyin Yang, Yu Dai, et al.
Frontiers in Medicine|February 21, 2022
Development of a Nomogram to Predict the Risk of Chronic Active Epstein-Barr Virus Infection Progressing to Hemophagocytic LymphohistiocytosisXiaodan He, Jingshi Wang, Deli Song, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|October 8, 2009
[Cloning, expression and the application of human, rat alcohol dehydrogenase and aldo-keto reductase]Ling-Bo Gao, Jin-Zhao Wang, Su Zeng
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 21, 2009
[Preliminary clinical analysis of the hepatic dysfunction in patients with acquired hemophagocytic lymphohistiocytosis]Ling-Zhi Yang, Jing-Shi Wang, Zhao Wang
Journal of Biomedical Optics|November 13, 2007
Modulation transfer function measurement of scanning reflectance microscopesZhao Wang, Christopher E Glazowski, James M Zavislan
Stem Cell Research & Therapy|July 3, 2020
HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single centerYue Song, Jingshi Wang, Yini Wang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 29, 2020
Metal-Containing Polydopamine Nanomaterials: Catalysis, Energy, and TheranosticsZhao Wang, Yuan Zou, Yiwen Li, et al.
Journal of Materials Science. Materials in Medicine|June 6, 2025
Glycopolymer nanomicelles: pH-responsive drug delivery, endocytosis pathway, autophagy behavior, and the effect of autophagy inhibitorsZhao Wang, Jingjing Sun, Lin Jia, et al.
Scientific Reports|July 2, 2025
Exploring the link between the ZJU index and sarcopenia in adults aged 20-59 using NHANES and machine learningHuan Chen, Ning Du, Hong Xiao, et al.
Annals of Hematology|April 5, 2025
CXCL9 and IL-18: potential biomarkers for efficacy evaluation in refractory hemophagocytic lymphohistiocytosis treated with RED (ruxolitinib, emapalumab and dexamethasone)Xuan Lan, Na Wei, Jingshi Wang, et al.
Pageof 238